Relx PLC

Publication date: November 20, 2024

content.featured_image_alt_text

 

 

 


- Year of incorporation:
1993 (formed from the merger of Reed International and Elsevier)

- Year added to the AEX: 1997

- Highest price ever: €45.26 in November 2024

- Average trading volume: Approximately 624.500 shares per day

- Choice over the past 12 months: +27.26%

 

 

 

 


Introduction about the company

RELX Group PLC is a leading international provider of information and analytics solutions for professional and enterprise markets. The company is headquartered in London, United Kingdom, and operates in more than 180 countries worldwide. RELX operates in a variety of sectors, including science, healthcare, legal services, risk management, and event management. RELX is listed on the Euronext Amsterdam and London Stock Exchange under the symbol REL and is known for its innovative use of data analytics and technology to support clients in decision-making and operational efficiency.

Core figures & performance

In 2023, RELX achieved revenues of approximately €11 billion, with an operating profit of €3.12 billion. Most of the revenue came from the Risk & Business Analytics and Scientific, Technical & Medical (STM) divisions. RELX has a market capitalization of approximately €79 billion, making it one of the largest companies in the information and data services industry. The company has consistently rewarded its shareholders with dividend growth, with an annual dividend payout of €0.55 per share by 2023.

History & development

RELX was founded in 1993 through the merger of publishing companies Reed International (UK) and Elsevier (NL). Since then, the company has undergone a transformation from a traditional publishing company to a data-driven technology company. Over the past two decades, RELX has made significant investments in digital platforms, analytics tools, and machine learning solutions, giving the company a strong foothold in its core markets.

A major recent development has been the continued expansion of RELX's data and risk management business, including strategic acquisitions of companies in emerging markets and the launch of new AI solutions within the healthcare and legal sectors.

Sector & competition

RELX operates within the global information and data services industry and faces strong competitors such as Thomson Reuters, Bloomberg, and Wolters Kluwer. The industry is characterized by the growing demand for data analytics and specialized digital solutions, as well as the rise of AI technologies. RELX stands out for its integrated approach, use of cutting-edge technology, and broad market diversification.

 

Yelza Money Care

Wekelijks onze analyses in je inbox.


Influence of RELX on the AEX

RELX has a significant influence on the AEX, with a weighting of approximately 8.69% (measured in 2024). As one of the largest companies in the index, RELX plays an important role in determining the overall performance of the AEX. RELX's share price movements are often influenced by demand for data services, macroeconomic trends, and investments in emerging technologies. The stock is considered a defensive choice within the index due to the company's stable revenue streams.

Investment analysis & outlook

RELX is considered a solid investment by analysts, thanks to its consistent revenue growth, profitability, and strong market dynamics. The company is benefiting from megatrends such as digitization, automation, and the growing need for risk management solutions. Risks include potential slowdowns in economic growth, increasing competition, and regulatory pressure in certain markets.

Below is RELX's share price performance compared to the AEX over the past five years. This shows that RELX has shown consistent growth, with less volatility than many other AEX-listed companies. Moreover, the comparison shows that RELX has grown significantly more than the AEX. 

RELX_price_5 years
News & updates

Recently, RELX announced that it is further expanding its focus on artificial intelligence, with new applications for legal and medical clients. The company is also investing in the development of its leading platforms such as LexisNexis and Elsevier ScienceDirect, which support increasing demand for data-driven solutions. In addition, RELX is considering expansion in Asian markets, where it has already shown significant growth.

For more information on RELX's performance and strategic plans, please visit its official website: RELX.com.

 

 

Disclaimer: Investing involves risk. Our analysts are not financial advisors. Always consult an advisor when making financial decisions. The information and tips provided on this website are based on our analysts' own insights and experiences. They are therefore for educational purposes only.